Stempeutics, a leader in allogeneic cellular medicines for inflammatory diseases, announced the publication of the Knee OA Phase 3 trial results in the premier journal, the American Journal of Sports Medicine (AJSM).
Osteoarthritis in people over 16: diagnosis and management – updated summary of NICE guidance Letter to the editor bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.
Acoustic Neuroma Drug Market 2032: Epidemiology, Clinical openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Lupus Nephritis Pipeline Drugs Analysis Report (2023 Updates): openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these drugs might have a disease-modifying effect for KOA.